I have L2 and I can see as the trades go off .. I've been
I have L2 and I can see as the trades go off .. I've been watching CANN this way... it's weird to see it with all the MM's missing and no b/a but you will definitely be able to get a general idea of what to put your order for either a buy or a sell.
Someone mentioned on another board that the orders had to match and it would be best to put in at round numbers... but I'm seeing trades go off .. 6 shares, 69, 42, yesterday, I even saw 1, yes a single share.
Can anyone make sense of it that understands the Greys better?
Growlife Inc. (PHOT) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The Plot Thickens with Innventure's DarkNX Project Buckle up, fellow market sling-riders; the Innventure tale is a rocky one for the books. Imagine this: You’ve plunked down your hard-earned cash on Innventure Inc. (NASDAQ: INV), lured by their glowing pronouncements about a supposed golden egg project, the Accelsius DarkNX data-center deal. A big talk about...
Continue Reading
Shaking Up the Window Screens Biz If you've been grinding in the window and door game, you know it's not an industry with a lot of buzz, but here comes a shot of caffeine. FlexScreen and RiteScreen just snagged David Whisenhunt to rev up their sales machine. Who's David Whisenhunt? Well, he's no rookie. With over two decades deep in the fenestration field, Whisenhunt...
Continue Reading
Leidos' Autonomous Leap with the U.S. Navy Well, today it's all about Leidos, an outfit that's been showing its grit in the world of maritime autonomy. Their systems aren't just tinkering around anymore—they're slicing through the waves at RIMPAC, the Rim of the Pacific, and running alongside the USS Theodore Roosevelt Carrier Strike Group. That's big news in anyone's...
Continue Reading
Why Early Detection of Gum Disease Matters Let's dive right into the crux of things. Gum disease, that sneaky antagonist of oral health, starts unassumingly. You brush, you floss, but those gums might still bleed—ever noticed? Dr. Marian Burgard of Fairport Family Dental has a thing or two to say about this, enlightening us through an insightful piece by HelloNation....
Continue Reading
Jollibee Partners with DreamWorks Animation Never thought I’d see the day: Jollibee, that familiar face of fast food, teaming up with the creative juggernaut DreamWorks Animation. They’re calling it a celebration of friendship and Filipino culture, wrapped up neatly in the context of a flick called Forgotten Island. Set to sizzle in theaters on September 25, 2026,...
Continue Reading
A Leap Forward in Cancer Care: Proton Therapy Revolution Dang, just when you think you've heard it all in cancer treatment, Fortis Healthcare drops a bombshell: India’s first upright proton therapy system. Boom! This isn't your run-of-the-mill radiation treatment we're talking about here. This is the futuristic flair of the MEVION S250-FIT™, featuring upright...
Continue Reading
Wildfire Risk in California: A Growing Alarm If there's one thing that's become a bitter truth over the years, it's that California and wildfires are inseparably linked, like mayo on a greasy diner BLT—except way worse for the gut. The latest round of data from Guidewire HazardHub is practically sounding the alarm bells louder than ever. Over a million homes in...
Continue Reading
The Big Move in Correctional Healthcare VitalCore Health Strategies has made an impressive move with the opening of a 60-bed Behavioral Health Unit at Shawnee County Jail in Topeka, Kansas. The unit, part of a $21 million expansion completed on August 24, is set to change the landscape for inmates needing mental health and substance use treatment. This isn't just a slap...
Continue Reading
New Options for Creative Home Exteriors Amid today's housing market rollercoaster, a sprinkle of bold innovation in building materials can make a statement—and that's precisely what Associated Materials Innovations (AMI) is banking on with their latest beef-up in the ASCEND® Composite Cladding lineup. Introduced out of Cuyahoga Falls on Sept. 8, 2026, this expansion...
Continue Reading
Driving Change at the Capital Invitational Let's talk about a powerhouse collaboration aiming to do more than just thrill basketball fans. We're looking at MADD Sports, Uber, and the Capital Invitational joining forces at The St. James in Springfield, Virginia, on December 10, 2026. This is not your average sporting event; it's a gathering with a bigger purpose. The...
Continue Reading
Top 5 Most Recently Viewed Articles
The Remarkable Journey of Kinsale Capital Group Kinsale Capital Group Inc (NYSE: KNSL) has shown substantial growth in the past five years, outperforming the market significantly. With an average annual return of 16.93%, it has outpaced market benchmarks by 4.13% over the same period. Currently, the company's market capitalization stands at an impressive $10.61 billion,...
Continue Reading
Searchlight Cyber Welcomes New COO Todd Crick Recently, Searchlight Cyber has made a significant move by appointing Todd Crick as Chief Operating Officer (COO). In this pivotal role, Todd will oversee operational processes and spearhead the company’s go-to-market strategy. With an impressive background in senior operations and consulting roles, including his tenure as...
Continue Reading
Buffalo Games Expands Portfolio with Boogie Board Acquisition Buffalo Games, a prominent consumer enrichment platform, is thrilled to announce a strategic acquisition that promises to enhance its innovative suite of products. The company has recently finalized the acquisition of Boogie Board, an industry leader in reusable drawing and writing tablets tailored for creative...
Continue Reading
Examining Trump Media's Current Standing Former President Donald Trump has made it clear that he plans to hold onto his $1.7 billion stake in Trump Media. While he remains committed to this decision, the upcoming end of certain restrictions may allow other insiders to take advantage of their investments. Who Are the Main Stakeholders? Trump Media & Technology Group...
Continue Reading
Rilzabrutinib Granted Orphan Drug Designation Rilzabrutinib, an innovative medication, has received orphan drug designation from the US Food and Drug Administration (FDA) for treating two rare diseases: warm autoimmune hemolytic anemia (wAIHA) and IgG4-related disease (IgG4-RD). This designation acknowledges the significant unmet medical need faced by patients affected by...
Continue Reading